Planned Parenthood League of Massachusetts

Through this project in 2017, Planned Parenthood League of Massachusetts (PPLM) offered etonogestrel hormonal implants at the time of mifepristone administration for women undergoing medical abortion. The project built on PPLM’s participation in a Gynuity Health Projects study that found this procedure was associated with both increased use of highly effective contraceptive methods six months later and increased patient satisfaction. PPLM also developed strategies to overcome anticipated barriers to providing this service, including education of the patient population, receipt of adequate reimbursement, and operational challenges to integrating the procedure within clinical practice.